Compare ARDX & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARDX | THFF |
|---|---|---|
| Founded | 2007 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 975.9M | 930.9M |
| IPO Year | 2014 | 1995 |
| Metric | ARDX | THFF |
|---|---|---|
| Price | $3.42 | $76.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | $15.14 | ★ $62.00 |
| AVG Volume (30 Days) | ★ 3.9M | 86.1K |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | N/A | ★ 67.00 |
| EPS | N/A | ★ 3.58 |
| Revenue | ★ $2,607,000.00 | N/A |
| Revenue This Year | $37.75 | $17.88 |
| Revenue Next Year | $34.24 | $4.03 |
| P/E Ratio | ★ N/A | $21.53 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.34 | $51.21 |
| 52 Week High | $8.40 | $84.17 |
| Indicator | ARDX | THFF |
|---|---|---|
| Relative Strength Index (RSI) | 24.11 | 35.09 |
| Support Level | N/A | $74.32 |
| Resistance Level | $3.92 | $78.57 |
| Average True Range (ATR) | 0.12 | 1.75 |
| MACD | 0.01 | -0.26 |
| Stochastic Oscillator | 14.53 | 23.28 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities. Company's loan portfolio was diversified in Commercial, Residential and consumer domains.